Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antiestrogens and normal human breast cell proliferation].

P Mauvais-Jarvis1, A Gompel, C Malet

  • 1Service de Médecine de la Reproduction, Hôpital Necker, Paris.

Annales D'Endocrinologie
|January 1, 1989
PubMed
Summary

Steroidal and non-steroidal antiestrogens, like tamoxifen, inhibit breast cell proliferation. Progestins and antiprogestins also impact cell growth and stimulate a progesterone receptor marker, particularly in estradiol-primed cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The importance of resident training in menopause.

Women & health·2025
Same author

Lack of evidence that progesterone in ovulatory cycles causes breast cancer.

Climacteric : the journal of the International Menopause Society·2023
Same author

Menopause hormone treatment after cancer.

Climacteric : the journal of the International Menopause Society·2023
Same author

Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study.

Gynecologic oncology·2021
Same author

Systemic lupus erythematosus and menopause.

Climacteric : the journal of the International Menopause Society·2019
Same author

Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Area of Science:

  • Endocrinology
  • Cell Biology
  • Pharmacology

Context:

  • Investigating the effects of steroidal and non-steroidal antiestrogens on normal human breast cells.
  • Comparing the antiproliferative actions of tamoxifen and its derivatives in various breast cell models.

Purpose:

  • To evaluate the antiproliferative potency of progestins and antiprogestins in breast cells.
  • To assess the impact of these agents on 17 beta-hydroxysteroid dehydrogenase activity as a marker for progesterone receptor function.

Summary:

  • Both steroidal (progestins) and non-steroidal antiestrogens (tamoxifen) exhibit potent antiproliferative effects on normal human breast cells.
  • Promegestone (R 5020) demonstrates strong antiproliferative activity, independent of estradiol. RU 486 also slows proliferation at higher concentrations, likely via progesterone agonist activity.

Related Experiment Videos

  • Progestins and antiprogestins stimulate 17 beta-hydroxysteroid dehydrogenase activity, a progesterone receptor marker, specifically in estradiol-primed cells.

    • Impact:

    • Provides insights into the mechanisms of action for antiestrogens and progestins in breast cell biology.
    • Highlights the role of estradiol priming in modulating the cellular response to progesterone receptor ligands.
    • Contributes to understanding potential therapeutic targets for breast cancer treatment and hormone-related conditions.